Well-scribed! Former Stem Cell Research Director, and now Gladstone Institutes Director Deepak Srivastava, MD has revolutionized the treatment of heart disease through three distinct but interrelated product platforms: Gene Therapy, Cellular Biofield Regeneration & Precision Medicina Therapeutics.
Well-scribed! Former Stem Cell Research Director, and now Gladstone Institutes Director Deepak Srivastava, MD has revolutionized the treatment of heart disease through three distinct but interrelated product platforms: Gene Therapy, Cellular Biofield Regeneration & Precision Medicina Therapeutics.
R. Eady, KR Therapeutics